Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sramek

Showing results (51-60 of 156) with videos related to

Pageof 16
Sort By:
Dialogues in Clinical Neuroscience|February 10, 2017
Sex differences in the psychopharmacological treatment of depressionJohn J Sramek, Michael F Murphy, Neal R Cutler
The Western Journal of Medicine|August 1, 1982
'Loads' alertA M Khajawall, J J Sramek, G M Simpson
Advances in Experimental Medicine and Biology|January 1, 1997
Erysipelas--its occurrence and clinical aspects in Prague, 1993. A retrospective studyV Hribalova, J Sramek, H Vojtechovska, et al.
The Mount Sinai Journal of Medicine, New York|October 1, 1996
Neuroleptic dosing in Asian and Hispanic outpatients with schizophreniaS Ruiz, P Chu, J Sramek, et al.
The Annals of Pharmacotherapy|May 1, 1992
Relationship between duration of illness and plasma concentrations of antipsychotics in psychotic patientsR Bera, S Roy, J Costa, et al.
The Annals of Pharmacotherapy|February 26, 1998
Potential for adverse events in patients with generalized anxiety disorderE J Frackiewicz-Koziol, J J Sramek, N R Cutler
Investigative Ophthalmology & Visual Science|March 1, 1987
Fibronectin distribution in the rat eye. An immunohistochemical studyS J Sramek, I H Wallow, C Bindley, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 1, 1987
Müller's cell involvement in proliferative diabetic retinopathyT M Nork, I H Wallow, S J Sramek, et al.
DICP : the Annals of Pharmacotherapy|January 1, 1990
Patterns of neuroleptic usage in continuously hospitalized chronic schizophrenic patients: evidence for development of drug toleranceJ J Sramek, V Gaurano, J M Herrera, et al.
Life Sciences|April 21, 1999
NXX-066 in patients with Alzheimer's disease: a bridging studyJ J Sramek, J Hourani, S S Jhee, et al.
Pageof 16

Showing results (51-60 of 156) with videos related to

Sort By:
Pageof 16
Dialogues in Clinical Neuroscience|February 10, 2017
Sex differences in the psychopharmacological treatment of depressionJohn J Sramek, Michael F Murphy, Neal R Cutler
The Western Journal of Medicine|August 1, 1982
'Loads' alertA M Khajawall, J J Sramek, G M Simpson
Advances in Experimental Medicine and Biology|January 1, 1997
Erysipelas--its occurrence and clinical aspects in Prague, 1993. A retrospective studyV Hribalova, J Sramek, H Vojtechovska, et al.
The Mount Sinai Journal of Medicine, New York|October 1, 1996
Neuroleptic dosing in Asian and Hispanic outpatients with schizophreniaS Ruiz, P Chu, J Sramek, et al.
The Annals of Pharmacotherapy|May 1, 1992
Relationship between duration of illness and plasma concentrations of antipsychotics in psychotic patientsR Bera, S Roy, J Costa, et al.
The Annals of Pharmacotherapy|February 26, 1998
Potential for adverse events in patients with generalized anxiety disorderE J Frackiewicz-Koziol, J J Sramek, N R Cutler
Investigative Ophthalmology & Visual Science|March 1, 1987
Fibronectin distribution in the rat eye. An immunohistochemical studyS J Sramek, I H Wallow, C Bindley, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 1, 1987
Müller's cell involvement in proliferative diabetic retinopathyT M Nork, I H Wallow, S J Sramek, et al.
DICP : the Annals of Pharmacotherapy|January 1, 1990
Patterns of neuroleptic usage in continuously hospitalized chronic schizophrenic patients: evidence for development of drug toleranceJ J Sramek, V Gaurano, J M Herrera, et al.
Life Sciences|April 21, 1999
NXX-066 in patients with Alzheimer's disease: a bridging studyJ J Sramek, J Hourani, S S Jhee, et al.
Pageof 16